A highly acclaimed figure in the pharmaceutical industry, Charles Armon Harbert, Ph.D., previously served as the vice president of the Groton Research Site associated with Pfizer, Inc. from 1993 until his retirement in 1999. Prior to this position, Dr. Harbert held several roles with Pfizer, Inc. between 1969 and 1993, including as a research scientist, project leader, manager, director, executive director and senior executive director. Among his greatest achievements includes being the co-inventor of the antidepressant drug Zoloft, serving as the leader of the chemistry team which first synthesized the drug.
Alongside his professional endeavors, Dr. Harbert participated in numerous capacities with a variety of organizations, including as co-chair of Keystone Symposium in 1995, a member of the visiting committee of Connecticut College in 1986 and 1993, and a member of the advisory committee in the Department of Chemistry of the University of Missouri from 1992 to 1999.
In preparation for his prolific career, Dr. Harbert earned a Ph.D. from the University of Missouri in 1967. He previously obtained a Bachelor of Science from the University of Colorado in 1962. Thereafter, he served as a postdoctoral fellow with the National Institutes of Health at Stanford University from 1967 to 1969.
A former member of the American Chemical Society, Dr. Harbert has been recognized numerous times for his exceptional accomplishments in the pharmaceutical industry. In 2005, he was honored with the Team Innovation Award from the American Chemical Society as a result of his discovery of Zoloft. He was presented with the Distinguished Alumni Award from the University of Missouri in 1993. He also holds several patents in the field for the conformational mapping of dopamine receptor antagonists.
Contact Charles Armon Harbert:
